Which has the lower trailing P/E, ACA or BLDR?

ACA has the lower trailing P/E: ACA trades at 14.70 and BLDR at 61.13. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ACA or BLDR?

Over the past five years, BLDR grew revenue faster — ACA at a 7.59% CAGR versus BLDR at 12.16%.

Does ACA or BLDR pay a bigger dividend?

ACA pays a dividend (0.14% yield), while BLDR has no payments in the available dividend history.

Is ACA or BLDR more profitable?

ACA runs the higher net margin — ACA at 17.90% versus BLDR at 0.71%.

How have ACA and BLDR total returns compared?

Over the past 5 years, ACA delivered 23.73% and BLDR delivered 1.08% annualized total return. Past performance doesn't predict future results.

Arcosa, Inc. (ACA) vs Builders FirstSource, Inc. (BLDR)

A side-by-side comparison of Arcosa, Inc. and Builders FirstSource, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 5, 2026. Differences are shown without an overall score or investment verdict.

ACA

Arcosa, Inc.

$7.21B

$146.75Basic MaterialsDelayed quote: Oct 5, 2026, 4:00 PM EDT

BLDR

Builders FirstSource, Inc.

$5.99B

$55.63Basic MaterialsDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — ACA vs BLDR

growth of $100 · dividends reinvested · last 8y

ACA +631.6% (+28.2%/yr)BLDR +351.9% (+20.7%/yr)ACA compounded faster over this window

ACA BLDR

ACA vs BLDR: by the numbers

•ACA is the larger company ($7.21B vs $5.99B market cap).
•ACA trades at the lower trailing earnings multiple (14.70 vs 61.13 P/E), one valuation lens rather than an overall verdict.
•ACA converts more revenue to profit (17.90% vs 0.71% net margin).
•BLDR grew revenue faster over the past five years (12.16% vs 7.59% CAGR).
•ACA pays a dividend (0.14% yield), while BLDR has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	ACA	BLDR
P/E ratio	14.70	61.13
Forward P/E	34.29	17.88
PEG ratio	1.03	7.74
P/S ratio	2.63	0.41
P/B ratio	2.42	1.49
EV / EBITDA	13.63	10.79
FCF yield	1.88%	10.68%

Profitability

Metric	ACA	BLDR
Gross margin	23.04%	29.19%
Operating margin	11.83%	3.02%
Net margin	17.90%	0.71%
ROE	16.47%	2.56%
ROIC	5.81%	3.18%

Dividends

Metric	ACA	BLDR
Dividend yield	0.14%	N/A
Payout ratio	2.00%	N/A

Growth (annualized)

Metric	ACA	BLDR
Revenue CAGR (5Y)	7.59%	12.16%
EPS CAGR (5Y)	14.08%	7.77%
FCF CAGR (5Y)	-0.26%	N/A
Total return CAGR (5Y)	23.73%	1.08%

Frequently asked

Which has the lower trailing P/E, ACA or BLDR?: ACA has the lower trailing P/E: ACA trades at 14.70 and BLDR at 61.13. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ACA or BLDR?: Over the past five years, BLDR grew revenue faster — ACA at a 7.59% CAGR versus BLDR at 12.16%.
Does ACA or BLDR pay a bigger dividend?: ACA pays a dividend (0.14% yield), while BLDR has no payments in the available dividend history.
Is ACA or BLDR more profitable?: ACA runs the higher net margin — ACA at 17.90% versus BLDR at 0.71%.
How have ACA and BLDR total returns compared?: Over the past 5 years, ACA delivered 23.73% and BLDR delivered 1.08% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ACA analysis Full BLDR analysis Interactive comparison tool

Dig into the metrics

Arcosa P/E ratio Builders FirstSource P/E ratio Arcosa dividend yield Arcosa ROE Builders FirstSource ROE Arcosa operating margin Builders FirstSource operating margin Arcosa revenue growth Builders FirstSource revenue growth Arcosa free cash flow Builders FirstSource free cash flow

Arcosa & Builders FirstSource appear in these rankings

Highest FCF Yield Stocks Highest 10-Year Total Return Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 5, 2026.